N-heterocyclic derivatives as NOS inhibitors

Details N-heterocyclic derivatives as NOS inhibitors N-heterocyclic derivatives as NOS inhibitors

2006-01-03

2006-01-03

Balasubramanian, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S326000, C514S396000, C514S397000, C546S210000, C540S603000, C548S343500

Reexamination Certificate

active

06982259

ABSTRACT:
N-Heterocyclic derivatives of the following formula:where m, n, p, A1, R1, R2, R3and R4are described herein, as well as other N-heterocyclic derivatives, are useful as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors of nitric oxide synthase and processes for synthesizing these compounds are also described herein.

REFERENCES:
patent: 5244865 (1993-09-01), Seitz et al.
patent: 5426110 (1995-06-01), Gossett et al.
patent: 5489591 (1996-02-01), Kobayashi et al.
patent: 5663334 (1997-09-01), Sheldrake et al.
patent: 6172005 (2001-01-01), Selby
patent: 6432947 (2002-08-01), Arnaiz et al.
patent: 6525051 (2003-02-01), Davey et al.
patent: 2002/0040024 (2002-04-01), Apodaca et al.
patent: 0 257 850 (1988-03-01), None
patent: 0 306 440 (1989-03-01), None
patent: 0 640 599 (1995-03-01), None
patent: 0 757 988 (1997-02-01), None
patent: 0 949 242 (1999-10-01), None
patent: WO96/14842 (1996-05-01), None
patent: WO96/14844 (1996-05-01), None
patent: WO98/09960 (1998-03-01), None
patent: WO01/14371 (2001-03-01), None
patent: WO02/32897 (2002-04-01), None
patent: WO03/022821 (2003-03-01), None
iFons et al. Cytokine ((7) 453-462, 1997.
Ohmori et al. J. Med. Chem. 39: 3971-3979, 1996.
Feldman et al., “The Surprising Life of Nitric Oxide”,Chemical and Engineering News(1993) 26-38.
Del Corona et al., “Synthesis and in vitro study of platelet antiaggregant activity of 2(4)-imidazol-1-yl-4(2)-cycloalkylaminopyrimidines”,Eur. J. Med. Chem.(1991) 26(7):729-733.
Fujisawa et al., “Inducible Nitric Oxide Synthase in a Human Glioblastoma Cell Line”,J. Neurochem.(1995) 64(1): 85-91.
Damiani et al., “Fluormetric Determination of Nitrite”Talanta(1986)33(8): 649-652.
Nathan, “Nitric oxide as a secretory product of mammalian cells”,FASEB Journal(1992) 6:3052-3064.
Lampe et al., “A novel Rearrangement of 1-(2-Aminoaryl)imidazoles”,J. Heterocyclic Chem(1994) 31:287-291.
Lis et al., “Synthesis of Novel (Aryloxy) propanolamines and Related Compounds Possessing Both Class II and Class III Antiarrhythmic Activity”J. Med. Chem.(1990) 33:2883-2891.

Affiliated with

Also associated with

Rating

N-heterocyclic derivatives as NOS inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-heterocyclic derivatives as NOS inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-heterocyclic derivatives as NOS inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3567689